EGFR and cancer: Moreover, co-expression of NGcGM3 and EGFR is a relatively frequent phenomena in cancer patients [28] and what it is more relevant the over-expression of both EGFR and NGcGM3 variant correlates with a worst prognostic in NSCLC patients [21] than the overexpression of either of these molecules separately.